FRANK D. RICKMAN, M.D.; ROBERT HANDIN, M.D.; JOHN P. HOWE, M.D.; JOSEPH S. ALPERT, M.D.; LEWIS DEXTER, M.D.; JAMES E. DALEN, M.D.
RICKMAN FD, HANDIN R, HOWE JP, ALPERT JS, DEXTER L, DALEN JE. Fibrin Split Products in Acute Pulmonary Embolism. Ann Intern Med. 1973;79:664-668. doi: 10.7326/0003-4819-79-5-664
Download citation file:
Published: Ann Intern Med. 1973;79(5):664-668.
The concentration of fibrin split products (FSP) was measured, by using a modification of the staphylococcal clumping test, in 46 patients who had pulmonary angiography for suspected acute pulmonary embolism and in 12 normal control subjects. The concentration was significantly higher in 19 patients with angiographically documented pulmonary embolism (mean FSP, 158 µg/ml) than in 22 patients without (mean, 8 µg/ml; P < 0.001)—in 18 of the 19 patients the concentration was > 10 µg/ml; in 19 of the 22 patients without pulmonary embolism it was 10 µg/ml or less. The levels were highest in patients with acute symptoms (<3 days) and in those with significant increases in total pulmonary resistance, as measured at cardiac catheterization. Fibrin split products concentration seems to be increased (>10 µg/ml) in most patients with acute pulmonary embolism. We had only one false-negative finding; however, the specificity of an elevation of this variable in acute pulmonary embolism needs further assessment.
Learn more about subscription options.
Register Now for a free account.
Emergency Medicine, Pulmonary/Critical Care, Venous Thromboembolism, Pulmonary Embolism.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only